lifestyle.pluralist.com

Category: Globe Newswire

Oxford Lane Capital Corp. Announces Further Detail on its Previously Announced 1-for-5 Reverse Stock Split

September 2, 2025
Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025
Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

September 2, 2025
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 2, 2025
PolarityBio Announces Launch of Expanded Access Treatment Protocol to Provide Continued Access to SkinTE® for Patients with Wagner 1 Diabetic Foot Ulcers

September 2, 2025
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML

September 2, 2025
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML

September 2, 2025
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 2, 2025
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 2, 2025